Inventor · disambiguated record
Jens Hasskarl
Also filed as: HASSKARL JENS
1 granted patent·5 pending applications·0 citations·filing 2018–2025
14Inventor score
Technology areasA61K
Top patents by PatentIndex Score
6 records- 0163US12263190B2Methods and combinations for treatment and T cell modulationJUNO THERAPEUTICS INC·Filed 2019·Granted Apr 1, 2025·0 cites·33 claims
- 0254US2025186503A1Methods and combinations for treatment and t cell modulationJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0344US2022401483A1Combination of a t cell therapy and (s)-3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidine-2,6-dioneJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0444US2021198372A1Methods for dosing and for modulation of genetically engineered cellsJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0542US2021121466A1Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitorJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0637US2021069246A1Combination therapy using adoptive cell therapy and checkpoint inhibitorCELGENE CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Hasskarl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →